MPAM
FLXN
Monarch Partners Asset Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-75,935
| Closed | -$680K | – | 184 |
|
|
2021
Q1 | $680K | Sell |
75,935
-2,235
| -3% | -$20K | 0.1% | 145 |
|
|
2020
Q4 | $902K | Sell |
78,170
-8,460
| -10% | -$97.6K | 0.16% | 144 |
|
|
2020
Q3 | $902K | Buy |
86,630
+27,920
| +48% | +$291K | 0.2% | 126 |
|
|
2020
Q2 | $772K | Buy |
58,710
+33,815
| +136% | +$445K | 0.19% | 111 |
|
|
2020
Q1 | $196K | Buy |
+24,895
| New | +$196K | 0.07% | 152 |
|
|
2018
Q4 | – | Sell |
-24,050
| Closed | -$450K | – | 223 |
|
|
2018
Q3 | $450K | Buy |
24,050
+3,260
| +16% | +$61K | 0.04% | 181 |
|
|
2018
Q2 | $537K | Sell |
20,790
-310
| -1% | -$8.01K | 0.05% | 172 |
|
|
2018
Q1 | $473K | Buy |
21,100
+7,560
| +56% | +$169K | 0.04% | 175 |
|
|
2017
Q4 | $339K | Sell |
13,540
-6,250
| -32% | -$156K | 0.03% | 174 |
|
|
2017
Q3 | $479K | Buy |
19,790
+480
| +2% | +$11.6K | 0.05% | 156 |
|
|
2017
Q2 | $390K | Buy |
19,310
+8,930
| +86% | +$180K | 0.04% | 159 |
|
|
2017
Q1 | $279K | Buy |
+10,380
| New | +$279K | 0.03% | 168 |
|